Warning about Reglan
Submitted by Marsha Miller Ph.D. on Fri, 02/27/2009
Metoclopramide (Reglan) poses risks to those with HD and PD.
Managing HD
FDA Notifies Public of Adverse Reactions Linked to Botox Use
Submitted by Marsha Miller Ph.D. on Tue, 02/12/2008
The FDA has information for your doctor about botox.
Anesthesia Warning - Isoflurane
Submitted by Marsha Miller Ph.D. on Sun, 01/27/2008
The anesthesia isoflurane (brand name Forane) should not be administered to HD patients.
Quality of life: patients and partners
Submitted by Marsha Miller Ph.D. on Sat, 05/19/2007
Researchers confirmed the obvious - that a caregiver's perception of progression is different than that of the HD patient.
Australian Rare Disease Guidelines for General Practitioners
Submitted by Marsha Miller Ph.D. on Mon, 08/21/2006
Australian doctors outline a strategy for the General Practitioners to deal with the occassional rare disease that they encounter.
Peer-Professional Workgroups in Palliative Care
Submitted by Marsha Miller Ph.D. on Mon, 08/21/2006
The Robert Woods Johnson Foundation has convened a number of workgroups to promote excellence in care for Huntington's and other patients.
Review of Medications for HD symptoms
Submitted by Marsha Miller Ph.D. on Sun, 07/25/2004
While we are all grateful for the research into potential treatments for Huntington?s Disease, in the meantime research into treatments of the symptoms has lagged behind. This is why it?s so importan
